Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland

Keyphrases

• Scotland 100%
• Clinical Practice 100%
• Atrial Fibrillation 100%
• Comparative Effectiveness 100%
• Direct Oral Anticoagulants 100%
• Comparative Safety 100%
• Rivaroxaban 100%
• Apixaban 83%
• All-cause Mortality 33%
• Myocardial Infarction 33%
• Dabigatran 33%
• Pulmonary Embolism 33%
• Systemic Embolism 33%
• High Risk 16%
• Hazard Ratio 16%
• Bleeding 16%
• Retrospective Cohort Study 16%
• Cox Proportional Hazards Model 16%
• Clinical Efficacy 16%
• Cardiovascular Mortality 16%
• Stroke Risk 16%
• Mortality Event 16%
• Routine Clinical Practice 16%
• Major Bleed 16%
• High Bleeding Risk 16%
• Linked Administrative Data 16%
• Bleeding Events 16%
• Clinical Safety 16%
• Preventing Stroke 16%
• Gastrointestinal Bleeding 16%
• Oral Anticoagulant Therapy 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Rivaroxaban 100%
• Atrial Fibrillation 100%
• Direct Oral Anticoagulant 100%
• Apixaban 83%
• Bleeding 33%
• All Cause Mortality 33%
• Heart Infarction 33%
• Ciclonicate 33%
• Lung Embolism 33%
• Dabigatran 33%
• Cohort Study 16%
• Thromboembolism 16%
• Population Study 16%